Critical Updates from the 2020 Scientific Sessions of the American Heart Association and National Lipid Association
January 1, 2021
See the latest updates
- All
- Breaking News
- Presentation
- Webinar
- Accredited
- Non-Accredited
- Conference Video
- 6-Minute Consult
- Transformative Teachers
- Primary Care Physician
- Specialist
- Allied Health Professional
-
-
D’Hier Protection À Aujourd’hui – session de français
November 10, 2020Décrire les besoins non satisfaits sur le plan médical pour la protection rénale -
Then & Now – The Kidney Protection Masterclass – PDT Session – October 1, 2020 19h 30
November 10, 2020Essential Learning for Vascular Surgeons, Cardiac Surgeons, Cardiologists, Internal Medicine Specialists, Primary Care Providers, Endocrinologists,... -
Then & Now – The Kidney Protection Masterclass – EDT Session – October 1, 2020 17h 30
November 10, 2020Essential Learning for Vascular Surgeons, Cardiac Surgeons, Cardiologists, Internal Medicine Specialists, Primary Care Providers, Endocrinologists,... -
Then & Now – The Kidney Protection Masterclass – CDT Session – October 1, 2020 19h 00
November 10, 2020Essential Learning for Vascular Surgeons, Cardiac Surgeons, Cardiologists, Internal Medicine Specialists, Primary Care Providers, Endocrinologists,... -
Coping with COVID-19: A Webinar For Healthcare Professionals
April 14, 2020The latest updates regarding COVID-19. -
Cardiometabolic Update from the American Heart Association Scientific Sessions 2019
January 15, 2020Reviewing the emerging pharmacotherapies for heart failure and contemporary challenges in identifying and optimizing management of heart failure. -
Webinar: It’s a New Day – A Breakthrough in Renal and Cardiac Benefits
May 21, 2019Experience the webinar for It’s a New Day – A Breakthrough in Renal and Cardiac Benefits -
It’s a New Day – A Breakthrough in Renal and Cardiac Benefits
April 27, 2019Discover key outcomes from 'It’s a New Day – A Breakthrough in Renal and Cardiac Benefits' -
Faire le lien entre diabète, insuffisance cardiaque et risque vasculaire Depuis la prévention jusqu’au traitement par des inhibiteurs du SGLT2 : intégration des nouvelles données probantes dans la pratique clinique
January 14, 2019Mettre en pratique le nouvel algorithme clinique pour utiliser un inhibiteur du SGLT2 chez les patients atteints d’une maladie vasculaire... -
Bridging the Gap between Diabetes, Heart Failure and Vascular Risk – From prevention to treatment with SGLT2i: Applying new evidence to clinical practice
January 14, 2019Discussing a new clinical algorithm to use SGLT2i in patients with vascular disease and heart failure -
Key Science at the EASD 2018: Implications for Practice
November 1, 2018Discover key scientific outcomes from EASD 2018
